| Literature DB >> 34774246 |
Karel Dandurand1, Dalal S Ali1, Aliya A Khan2.
Abstract
Hypercalcemic disorders are rare in pregnant women and are usually due to primary hyperparathyroidism. Clinical manifestations of hypercalcemia are nonspecific and can be masked by the physiologic changes of pregnancy. Furthermore, routine antenatal screening does not include serum calcium measurement and a hypercalcemia diagnosis may therefore be delayed until term or even after delivery. Timely recognition and appropriate interventions are essential to decrease maternal and fetal complications. Conservative measures are appropriate in the presence of mild hypercalcemia. Parathyroidectomy remains the mainstay of treatment for primary hyperparathyroidism with significant hypercalcemia not responding to conservative measures.Entities:
Keywords: Calcitonin; Cinacalcet; Hypercalcemia; Management; Parathyroidectomy; Pregnancy; Primary hyperparathyroidism
Mesh:
Substances:
Year: 2021 PMID: 34774246 DOI: 10.1016/j.ecl.2021.07.009
Source DB: PubMed Journal: Endocrinol Metab Clin North Am ISSN: 0889-8529 Impact factor: 4.741